Publications by authors named "Kensuke Ofuchi"

Claim this Profile
I
Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial.
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Norie Watahiki, Kensuke Ofuchi

Front Endocrinol (Lausanne)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI study.
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Norie Watahiki, Kensuke Ofuchi

Front Endocrinol (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of clinical glycemic control markers treated with imeglimin and its effect on erythrocytes in patients with type 2 diabetes mellitus: study protocol of a single-arm, open-label, prospective, exploratory trial.
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Satako Douguchi, Kensuke Ofuchi

Front Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia.
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Norie Watahiki, Kensuke Ofuchi

Diabetes Metab Syndr Obes· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetic kidney disease: Protocol for a single-arm, open-label, prospective, exploratory study.
Takeshi Osonoi, Miyoko Saito, Mitsuru Hosoya, Satako Douguchi, Kensuke Ofuchi

Front Endocrinol (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of barley intake on glycemic control in Japanese patients with type 2 diabetes mellitus undergoing antidiabetic therapy: a prospective study.
Takeshi Osonoi, Tsubasa Matsuoka, Kensuke Ofuchi, Makoto Katoh, Toshiki Kobayashi

Diabetol Int· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liraglutide Improves Estimated Glomerular Filtration Rate Slopes in Patients with Chronic Kidney Disease and Type 2 Diabetes: A 7-Year Retrospective Analysis.
Takeshi Osonoi, Miyoko Saito, Yusuke Osonoi, Satako Douguchi, Kensuke Ofuchi

Diabetes Technol Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study.
Takeshi Osonoi, Miyoko Saito, Naoya Koda, Satako Douguchi, Takako Nakano, Kensuke Ofuchi

Diabetes Metab Syndr Obes· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study.
Takeshi Osonoi, Atsuko Tamasawa, Yusuke Osonoi, Kensuke Ofuchi, Makoto Katoh

Diabetes Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis